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Purpose: Biallelic crumbs cell polarity complex component 1 (CRB1) mutations can
present as Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), or cystic
maculopathy. This study reports a novel phenotype of asymptomatic fenestrated slit
maculopathy (AFSM) and examinesmacular volume profile andmicroperimetry as clini-
cal trial end points in CRB1-associated retinopathies.
Methods: Twelve patients from nine families with CRB1mutation were recruited. Ultra-
widefield (UWF) color fundus photography and autofluorescence (AF), spectral-domain
optical coherence tomography (SD-OCT), microperimetry, and adaptive optics (AO)
imaging were performed. Macular volume profiles were compared with age-matched
healthy controls. Genotyping was performed using APEX genotyping microarrays,
targeted next-generation sequencing, and Sanger sequencing.
Results: We identified one patient with LCA, five patients with RP, and four patients
withmacular dystrophy (MD)withbiallelicCRB1mutations. Two siblingswith compound
heterozygote genotype (c.[2843G>A]; [498_506del]) had AFSM characterized by local-
ized outer retinal disruption on SD-OCT andparafoveal cone loss onAO imaging despite
normal fundus appearance, visual acuity, and foveal sensitivity. UWF AF demonstrated
preserved para-arteriolar retinal pigment epithelium (PPRPE) in all patients with RP.
Microperimetry documented preserved central retinal function in six patients. The ratio
of perifoveal-to-foveal retinal volume was greater than controls in 89% (8/9) of patients
with RP or MD, whereas central subfield and total macular volume were outside normal
limits in 67% (6/9).
Conclusions: AO imaging was helpful in detecting parafoveal cone loss in asymp-
tomatic patients. Macular volume profile and microperimetry parameters may have
utility as CRB1 trials end points.
Translational Relevance:Macular volume and sensitivity can be used as structural and
functional end points for trials on CRB1-associated RP and MD.
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Introduction
Crumbs cell polarity complex component 1 (CRB1;
OMIM: #604210) is a transmembrane protein, located
within the subapical region of human photoreceptors
that plays a critical role in retinal development, struc-
ture, and function.1,2 Biallelic mutations in CRB1 have
been implicated in 3% to 9% of autosomal recessive
retinitis pigmentosa (arRP), including retinitis pigmen-
tosa 12 (RP12; OMIM: #600105)3 and 7% to 17%
of Leber congenital amaurosis (LCA), also known
as LCA8 (OMIM: #613835).4,5 Maculopathy with
or without foveal schisis is a more recently recog-
nized phenotype associated with CRB1 mutations.6–11
Given gene therapy for CRB1-associated retinopa-
thy is already underway in an animal model,12 it is
timely to examine the various imaging biomarkers
that could be considered in future CRB1 treatment
trials.
CRB1-associated retinitis pigmentosa (CRB1-RP)
has been associated with coarse retinal lamination,
thick retina, preserved para-arteriolar retinal pigment
epithelium (PPRPE), hypermetropia, cystoid macular
edema (CMO), and retinal telangiectasia with Coat’s-
like reaction.13 For example, the likelihood of detecting
CRB1 mutation in patients with RP is higher among
those presenting with PPRPE (66%–74%) or retinal
telangiectasia (31%–53%).4 Jacobson and colleagues
reported abnormal parafoveal retinal thickening in
eight patients with CRB1-associated LCA or early-
onset severeRP.14 Their study used low resolution time-
domain optical coherence tomography (OCT) cross
section images without thickness mapping and only
a relatively small number of healthy control subjects
were recruited (n = 3). In a cohort of 55 patients with
CRB1-RP, Talib et al. reported perifoveal retinal thick-
ening in 82% (9/11) of patients and PPRPE in 26%
(13/50) and 33% (3/9) of patients on widefield color
composite fundus photographs and fundus autofluo-
rescence (FAF) imaging, respectively.15 Although these
cases were followed for 15.4 years, adaptive optics (AO)
imaging and microperimetry data were not presented.
Whereas universal functional markers, such as full-
field stimulus and pupillography, may be used as trial
end point in patients with late-stage RP caused by
CRB1 mutations,16 they may not be useful in patients
with early-stage RP or maculopathy. Hence, more
localized functional tests are required for monitoring
disease progression in patients with the latter manifes-
tation of CRB1, which is gaining recognition as an
important differential diagnosis of inherited isolated
cystic maculopathy. CRB1-associated maculopathy is
typically associated with a 9-bp deletion in exon 2,9–11
with few exceptions.7,8 Unlike CRB1-RP, patients
with maculopathy can be myopic8 and have a well-
developed retinal structure.7 The hallmark of CRB1-
maculopathy in OCT is early-onset schitic/cystoid
maculopathy, which resolves during several years
to decades leading to severe macular atrophy.10,11
However, none of the previous studies quantified
the retinal sensitivity and macular volume param-
eters. In addition, there has been no report of a
patient with biallelic CRB1 mutation with normal
visual acuity and no apparent macular architectural
change.
In the present study, we use multimodal retinal
imaging and microperimetry to characterize structural
and functional changes in CRB1-associated LCA, RP,
andmaculopathy. In addition, we describe a previously




The participants in this case series were enrolled
as part of the Western Australia Retinal Degenera-
tion (WARD) Study. Genetic diagnosis was estab-
lished through the Australian Inherited Retinal
Disease Registry and DNA Bank. The study proto-
col adhered to the tenets of the Declaration of
Helsinki and ethics approval was obtained from the
Human Ethics Committee of the Office of Research
Enterprise, The University of Western Australia
(RA/4/1/7916), and Sir Charles Gairdner Hospi-
tal Human Research Ethics Committee (approval
number 2001–053). Written informed consent was
obtained from the participants prior to inclusion in the
study.
Study Protocol and Clinical Assessment
Diagnosis of inherited retinal disease (IRD) was
confirmed by an experienced retinal specialist (author
F.K.C.) based on history and clinical examination
and/or electroretinography (ERG). Clinical assessment
involved obtaining a full medical and ocular history,
best-corrected visual acuity (BCVA), and dilated
fundus examination. ERG (RETIport version 3.2;
Roland Consult, Brandenburg, Germany, or in-house
custom built) was recorded in accordance with Interna-
tional Society for Clinical Electrophysiology of Vision
(ISCEV) standards.17 Assessment of visual fields was
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undertaken using fundus-controlled microperimetry
(Macular Integrity Assessment [MAIA] perimeter;
CenterVue, Padova, Italy). The large 10-2 (68 test loci)
and the small radial (37 test loci, 37R) grid patterns
were used to map the retinal sensitivity profile within
themacular (central 20 degrees field) and foveal (central
6 degrees field) regions, respectively (Supplementary
Figs. S1A, S1B).
Detailed multimodal imaging was performed in all
cases, including widefield color fundus photography
and green-light fundus autofluorescence (Califor-
nia; Optos plc., Dunfermline, UK) and spectral
domain optical coherence tomography (SD-OCT,
Spectralis; Heidelberg Engineering, Heidelberg,
Germany). Fovea-centered macular volume scans
were performed in a 30 degrees × 25 degrees area
covering the early treatment diabetic retinopathy study
(ETDRS) 1, 3, and 6 mm grid pattern (Supplementary
Fig. S1C). Volume scans consisted of 61 horizontal
B-scans separated by approximately 130 μm between
each scan. Inner limiting membrane and Bruch’s
membrane were segmented automatically using the
manufacturer software (HEYEX version 1.9.14.0;
Heidelberg Engineering) and adjusted manually by
a trained ophthalmologist (author D.R.) in cases
with segmentation error. A dense raster 15 degrees
× 10 degrees volume scan (97 slices, 30 μm inter-
vals) was performed in cases with central residual
island of vision to visualize the en face reflectance
map of the interdigitating zone (IZ). Autofluores-
cence (AF) imaging was performed using a scanning
laser ophthalmoscope (Spectralis HRA2; Heidelberg
Engineering) with short-wavelength AF (SW-AF;
λ = 488 nm) and near-infrared AF (NI-AF; λ =
787 nm) modalities. Flood-illumination AO retinal
imaging using rtx1 AO camera (Imagine Eyes, Orsay,
France) was performed in selected patients (n =
3) with fixation ability and without cataract and
CMO. Multiple overlapping 4 degrees × 4 degrees
images covering the central 6 degrees were taken at
the photoreceptor level. Individual tiles were stitched
together using i2k Retina software (DualAlign LLC,
Clifton Park, NY, USA) and overlayed on high-
resolution IR + OCT image. The location of the
fovea was marked on the montaged AO image of each
eye.
To compare SD-OCT macular volume measure-
ments in a normal population, 80 control subjects were
grouped into three age categories: 20 to 40 years (n =
19), 41 to 60 years (n = 36), and 61 to 75 years (n =
25). Mean and standard deviations of macular volume
indices were calculated for each age subgroup (Supple-
mentary Table S1).
OutcomeMeasures
BCVA was measured using the ETDRS chart and
recorded as ETDRS letter score and converted to
Snellen equivalents. Microperimetry point-wise sensi-
tivity (PWS) was classified into normal sensitivity (≥25
dB), relative scotoma (0–24 dB), or absolute scotoma
(<0 dB). Mean retinal sensitivity (MS), number of
scotomatous loci and number of seeing loci (sensitiv-
ity ≥0 dB) were reported for both the small radial and
10-2 grids.
The ETDRS grid (6 mm diameter) central subfield
volume (CSV; 1 mm diameter), total macular volume
(TMV), and average volume of the inner and outer
ETDRS rings at four quadrants were recorded for each
OCT volume scan. In addition, ratio of the TMV, outer
ring volume (ORV) and inner ring volume (IRV) to
CSV were calculated. AO images were analyzed using
AODetect version 3.0 (Imagine Eyes). Cone density
(CD) was measured at 2 degrees, 3 degrees, and 4
degrees along 4 meridional directions (Supplementary
Fig. S1D) and angular values (cell/deg2) were reported.
Patients’ CD values were compared with normal rtx1
ranges (average ± 2 SD) reported by Legras and
colleagues.18 In addition, previously validated custom
software19 was used for semi-automated segmentation
of AO montages to create a parafoveal cone density
map.
Genotyping and Pathogenicity Assessment
Genomic DNA samples were collected, processed,
and stored as previously described.20 Genomic DNA
was analyzed using the APEX ARRP microar-
ray (Asper Biotech, Estonia), bidirectional Sanger
sequencing (Macrogen, Seoul, South Korea, or
Asper Biotech), or various next-generation sequencing
(NGS) panels,21 and confirmed by Sanger sequenc-
ing (Casey Eye Institute, CEI Molecular Diagnostics
Laboratory, Portland, OR, USA, or Molecular Vision
Laboratory, Hillsboro, OR, USA). Cascade testing of
family members was analyzed by Sanger sequencing,
performed at CEI, the Australian Genome Research
Facility (AGRF; Perth, WA, Australia), or at the Lions
Eye Institute (Supplementary Table S2).
Variants are described in accordance with Human
Genome Variation Society recommendations.22
Pathogenicity was assessed usingM-CAP,23 REVEL,24
Mutation Taster,25 PolyPhen2,26 SIFT, SIFT Indel,27
VEST Indel,28 and the Alamut Visual Splicing Suite,
with information sought fromLOVD, ClinVar, dbSNP,
HGMD,29 Exome Sequencing Project, and gnomAD.30
Pathogenicity was interpreted in accordance with
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Figure 1. Pedigrees of families with CRB1-associated Leber congenital amaurosis (A), retinitis pigmentosa (B–E), and maculopathy (F–I). A
novel phenotype (asymptomatic fenestrated slit maculopathy) was observed in two siblings (II:2 and II:4) of family 2647 I, whereas the other
sibling (II:3) had typical macular dystrophy.
current guidelines proposed by the American College
of Medical Genetics and Genomics and the Associ-
ation for Molecular Pathology,31 and associated
literature.32,33
Statistical Analysis
Data were recorded in Statistical Package for the
Social Sciences (SPSS) version 23 (SPSS/IBM, Inc.,
Chicago, IL, USA) and appropriate statistics applied
after testing for normality. Quantitative data are
presented as the mean (SD, range) and categorical
data are presented as absolute numbers (%). For the
macular volume parameters, the average and SD of
the age-matched healthy subjects were calculated and
values above or below 2 SDwere considered significant.
Z-scores of the patients’ macular volume measure-
ments were calculated as ([patient value − normal
average]/SD). Rates of annual change in macular
volume parameters were calculated using linear regres-
sion analysis and beta estimates were reported.




Twelve patients (5 male patients and 7 female
patients) from nine Caucasian Australian families
were recruited (Fig. 1). Patients were denoted by
pedigree number and generation:individual. Mean age
(SD, range) at baseline examination was 35 (16, 11–
68) years. The mean (SD, range) age at onset of
symptoms was 9 (7, 0–21) years. Demographics, clini-
cal characteristics, and genotype are summarized in
Table 1.
Spectrum of Phenotypes
Based on the pattern of retinal involvement on
ultra-widefield FAF, patients were categorized into two
groups, namely pan-retinopathy or maculopathy. Pan-
retinopathy was further categorized into LCA and RP
according to the age of onset and ocular findings.
Maculopathy was categorized into macular dystrophy
Downloaded from tvst.arvojournals.org on 06/15/2021
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Figure2. Ultra-widefield color fundusphotographandautofluorescence (AF) imaging showdiffusenummularpigmentationandcomplete
loss of normal AF in patient with Leber congenital amaurosis (A) andmidperipheral bone-spicule pigmentation and hypo-autofluorescence
with central preservation of retinal pigment epithelium in patients with retinitis pigmentosa (RP) phenotype (B–F). Note that preserved
para-arteriolar RPE (PPRPE) is best visualized in AF imaging in all patients with RP B to F. Maculopathy presented with extensive macular
atrophy incorporating the optic disc (G, H) with some residual temporal macular autofluorescence H, or localized superotemporal hypo-
autofluorescence surrounded by hyperautofluorescent area (I), or normal fundus appearance and a macular hyperautofluorescent ring in
AF (J) in patients with macular dystrophy, or unremarkable fundus and AF in two patients with asymptomatic fenestrated slit maculopathy
(K, L). Mild loss of normal macular hyperautofluorescence and incomplete hyperautofluorescent ring may be noted in patient 2647/II:2 K.
Note that patients 2647/II:3 J and 2647/II:4 L are di-zygotic twins with different presentations.
(MD) and asymptomatic fenestrated slit maculopa-
thy (AFSM) based on symptoms and multimodal
imaging findings. Using this classification, we had one
patient with LCA, five patients with RP, four patients
with MD, and two patients with AFSM (Fig. 2). Of
note, patients 2647/II:3 and II:4 who were diagnosed
with MD and AFSM, respectively, were di-zygotic
twins.
Central Retinal Function in Symptomatic
Patients
Foveal and/or macular function was evaluated
using microperimetry in 6 out of 10 symptomatic
patients with severe outer retinal atrophy (3 RP and
3 MD). Serial microperimetry was available in 2
patients with RP (0432/II:4 and 2118/II:1) and 2
patients with MD (0625/II:1 and 0237/II:2; Fig. 3).
Patient 0432/II:4, 48 years old, with RP, responded
to 25/37 foveal stimuli and the foveal MS was 6.5
dB, whereas her BCVA was 20/250 (see Fig. 3A).
After 4 years, the number of foveal seeing loci
and foveal MS reduced to 20/37 loci and 4.9 dB,
respectively (see Fig. 3C). The foveal sensitivity and
number of seeing loci were 12.2 dB and 32/37, respec-
tively, in the 29 year old patient with RP (see Fig.
3E). Patient 2118/II:1, 11 years old with RP, had
a baseline macular seeing loci count and MS of
31 and 4.6 dB, respectively (see Fig. 3F). Follow-
up examinations revealed persistent improvement in
macular sensitivity over a 3-year period (see Figs.
3G, 3H). Patient 0625/II:1 with advanced MD (47
years old) had a BCVA of 20/125 in her better eye
Downloaded from tvst.arvojournals.org on 06/15/2021
Spectrum of CRB1-Associated Retinopathy Phenotypes TVST | February 2021 | Vol. 10 | No. 2 | Article 38 | 7
Figure 3. Microperimetry showed residual foveal and/or macular function in patients with retinitis pigmentosa (RP) (A–H) and macular
dystrophy (MD) (I–P). Central retinal function was recorded despite very low visual acuity (20/250) in the left eye of a 48 year old patient
with advanced RP at baseline A and B, which declined after 4 years C and D. The 29 year old patient with RP showed greater foveal
MS and number of seeing loci E. A fairly good baseline macular sensitivity with persistent improvement during a 3-year period was
observed in the 11 year old patient with RP F to H. The 43 year old patient with advanced MD who presented with extensive macular
atrophy responded only to stimuli presented at the central 2 degrees (I–J). Follow-up examinations showed stable function over a 4-
year period (K–L). Patient 0237/II:2 presented with localized superotemporal scotoma in 10-2 test corresponding to the atrophic area,
which progressed over 4 years of follow-up (M–O). The youngest patient with MD responded to all 68 presented 10-2 test loci with
mild central depression (P). MS, mean sensitivity; SL, number of seeing loci. Color coding of threshold values is shown on the right
side.
(right eye) and could see only 3 stimuli on foveal
grid with a mean sensitivity of 0.2 dB at baseline,
which remained stable after 4 years (see Figs. 3J–L).
An unusual microperimetry pattern was observed in
patient 0237/II:2 characterized by a localized super-
otemporal scotoma on the 10-2 grid. Follow-up exami-
nation after 3 and 4 years showed enlargement of
the scotoma and significant decrease in macular MS
(Figs. 3M–O).
Only two patients withMD underwent ERG testing
where patient 0237/II:2 showed a normal rod and
subnormal cone response in full-field ERG and patient
2647/II:3 had features on multifocal and pattern ERG
suggestive of macular dysfunction.
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Fundus Autofluorescence and SD-OCT in
Symptomatic Patients
Ultra-widefield AF showed diffuse hypo-
autofluorescence in patients with pan-retinopathy
and highlighted PPRPE and a variable-sized central
island of preserved retinal pigment epithelium (RPE)
in all patients with RP phenotype, regardless of age
and disease severity (see Figs. 2B–F and Supplemen-
tary Figs. S2A–E). SD-OCT over the PPRPE showed
remnants of outer retinal and RPE structures block-
ing choroidal transmission of light (Supplementary
Fig. S2F). Patients with MD revealed either exten-
sive macular hypo-autofluorescence incorporating
the optic disc in patients 0116/II:3 (68 years old) and
0625/II:1 (47 years old), localized superotemporal
hypo-autofluorescence in patient 0237/II:2 (30 years
old) or macular hyperautofluorescent ring in patient
2647/II:3 (23 years old; Figs. 2G–J).
Macular SD-OCT showed coarse retinal lamination
in patients with RP and diffuse outer retinal atrophy
in all patients (Supplementary Fig. S3). Although
remnants of photoreceptor layer were detected in all
patients, an EZ line was visible only in 1 patient with
RP and 3 patients with MD (Supplementary Figs.
S3E, S3H, S3I, S3J). Bilateral cystoid maculopathy
was observed in baseline OCT of patient 0237/II:2 and
retrospective OCTs of patient 2647/II:3. Serial macular
OCT revealed resolution of cystoid spaces and progres-
sive outer retinal atrophy in both patients (Fig. 4). In
addition, mild cystoid change was detected in three
patients withRP phenotype (Supplementary Figs. S3B,
S3C, S3F).
Macular Volume Profile
Baseline macular volume scan was available for
11 patients. None of the patients (including those
with CMO in retrospective OCT scans) had cystoid
maculopathy at the time of baseline imaging for the
macular volume study and during follow-up phase.
CSV was significantly lower than age-matched healthy
controls in three of five patients with RP and three of
four patients with MD, whereas TMV and ORV were
significantly higher in four of five patients with RP
and lower in two of four patients with MD. The ratio
of TMV/CSV and ORV/CSV was higher than control
group in four of five patients with RP and four of
four patients withMD (8/9 symptomatic patients), with
greater Z-scores for ORV/CSV (Table 2). All macular
volume parameters were within normal ranges in the
two patients with AFSM (see Table 2).
Longitudinal macular volume data were available
in 10 patients (8 symptomatic and 2 asymptomatic)
with a mean (SD, range) follow-up duration of 3.7
(1.9, 1.2–7.2) years. CSV declined at a rate of 0.002 to
0.004 mm3 per year in 5 patients (3 RP and 2 MD)
aged 35 years or above and increased at a rate of 0.003
to 0.006 mm3 per year in 3 patients (2 RP and 1 MD)
aged below 30 years. Conversely, TMV/CSV, IRV/CSV,
and ORV/CSV increased in patients aged 35 years
and above and declined in symptomatic patients aged
below 30 years. This age-dependent pattern was not
detected in TMV, IRV, and ORV change (Supplemen-
tary Table S3). Plotting volume measurements against
age highlighted this age-dependent pattern, which was
more prominent for TMV/CSV (Figs. 5A–C). Longi-
tudinal change in OCT B-scan and macular volume
profile in a 48 year old patient with RP with more
than 7 years follow-up is shown in Figures 5D and 5E.
Interestingly, despite significant decline in both CSV
and TMVwith increasing age, TMV/CSV ratio showed
a significant increase (see Fig. 5, Supplementary
Table S3).
Multimodal Imaging in AFSM
Both patients with AFSM had normal BCVA,
fundus appearance, and foveal sensitivity (Figs. 6A,
6F). However, NI-AF imaging revealed a horizontal
linear hypo-autofluorescence marking (Figs. 6C, 6H)
and corresponding attenuation of the subfoveal EZ
and IZ on vertical dense raster SD-OCT scan in both
patients, which was more evident on en face EZ map
(Figs. 6D, 6E, 6I, 6J). AO cone density map showed
moderate cone loss in the parafoveal region, which
was more pronounced in the older sibling (Fig. 7A).
Quantitative analysis of AO images showed low CD at
2 degrees eccentricity on all meridians in both patients
with AFSM and 3 degrees and 4 degrees eccentricities
on inferior and superior meridians in the older sibling
(2647/II:2), as compared with normal ranges (Fig. 7B,
Supplementary Table S4).
Genetic Analysis
Genetic analyses identified 14 different CRB1
variants in this cohort (Supplementary Fig. S4),
including 6 missense variants, 2 in-frame deletions, 2
nonsense variants, 2 splice site/near splice site variants,
1 frameshifting variant, and 1 substitution variant
resulting in an in-frame exon deletion.34 Of these,
11 were reported variants, including 1 hypomorphic
variant, and the remaining 3 were novel. Of these, 13
were assessed as likely pathogenic or pathogenic and 1
was a novel variant of uncertain significance (Supple-
mentary Table S5).
Downloaded from tvst.arvojournals.org on 06/15/2021
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Figure 4. Natural history of cystoidmaculopathy in two patients withmacular dystrophy. Serial SD-OCT in patient 0237/II:2 (A–G) showing
severe cystoidmaculopathy at baselineA and gradual resolution of the intraretinal fluidB toD, followedby progressive outer retinal atrophy
and perifoveal thickeningD toG. Similar pattern was observed in patient 2647/II:3 as documented in retrospective time-domain OCT (H–K)
and SD-OCT (L–N). Serial imaging in both patients revealed progressive attenuation and shortening of the ellipsoid zone (EZ). However, the
span of the residual EZ was not measurable due to severe macular edema.
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Figure 5. Longitudinal changes in central subfield volume (CSV), total macular volume (TMV) and TMV/CSV ratio in eight patients (5 with
retinitis pigmentosa and 3 with macular dystrophy) are shown in panels (A, B, and C), respectively. CSV increased in patients below 30 (n =
3) and declined in patients above 30 (n = 5) with increasing age A. TMV/CSV demonstrated a similar pattern, but in the opposite direction
C. An exampleof cross-sectionB-scanof patient 0432/II:4 at baseline andafter 8 years followup is presented (D), beside volumeand thickness
change map (E). Central 1, 3, and 6 mm boundaries on B-scans are marked using yellow, blue, and green vertical lines, respectively. Despite
notable decline in CSV (−0.03 mm3) and TMV (−0.86 mm3), the ratio of TMV/CSV increased by 6.02 E.
Discussion
Pathogenic variants in CRB1 result in a wide
spectrum of inherited retinal diseases ranging from
LCA and adult-onset RP to maculopathy.6,13 Accurate
monitoring of disease progression has been hampered
by the significant functional and structural damage
already present at the time of diagnosis in most
patients.16 Based on widefield FAF, we observed two
broad CRB1 phenotypes: a pan-retinopathy and a
maculopathy. We noted that all patients with RP
had clearly visible PPRPE on widefield FAF. In both
pan-retinopathy and maculopathy groups, we were
able to quantify foveal sensitivity and the unique
macular volume profile even in advanced stages of the
disease. Furthermore, we report compound heterozy-
gous mutations in CRB1 that resulted in both an MD
and a previously undescribed phenotype of AFSM
within the same family. We also report three novel
mutations, including a splicing variant (c.652+5G>C)
in one patient with MD, which is predicted to cause
aberrant splicing and is likely pathogenic.
Microperimetry: A Potential Functional End
Point in CRB1-Retinopathy
Feasibility of microperimetry was previously shown
in one patient with advancedCRB1-maculopathy using
MP1 microperimeter (Nidek Technologies, Padova,
Italy).7 The patient in this study was a 45-year-old
woman who carried compound heterozygous CRB1
mutations, c.[3991C>T];[4142C>T]. Using 10-2 grid,
the patient could respond to only 2 parafoveal stimuli
in the better eye at baseline, which reduced to 1 stimu-
lus after 5 years.7 We expand these findings to a
larger sample of patients with CRB1 with varying
disease phenotypes and severities and using the two
MAIA grid patterns, and report a wide range of
residual retinal sensitivities and progression patterns
(see Fig. 3). We also demonstrate functional disease
progression using both foveal (6 degrees) and macular
(10-2) grids, although stable or improving function
were also detected. For instance, we observed increas-
ing MS and number of seeing loci in our 11-year-
old patient with RP (Figs. 3G, 3H), which may be
explained by lower sensitivity and higher variability of
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Figure 6. Microperimetry and multimodal imaging in the two patients with asymptomatic fenestrated slit maculopathy (AFSM). Both
patients had 20/20 or better visual acuity andnormal foveal sensitivity (A) and (F). Near-infrared autofluorescence (NI-AF) revealed a horizon-
tal slit-like hypo-autofluorescent line (red arrows) in both patients (B, C and G, H). Vertical dense raster SD-OCT imaging through the hypo-
autofluorescent lesion (green lines in panels C andH) demonstrated attenuated ellipsoid zone (EZ) and interdigitating zone (IZ) beneath the
fovea (D and I, yellow arrows). Reconstructed en face EZ map highlighted the slit-like EZ defect (red arrows) in both patients (E and J). There
is a minor vessel misalignment between EZ en face reconstructions and background infrared image in panel E, which is not expected to
affect the morphology of the EZ defect. Normal OCT (K) and en face EZ map (L) using the same protocol in an age-matched healthy control
is presented for comparison.
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Figure 7. Adaptive optics (AO) imaging findings in three siblings from family 2647 at same age range. Panel (A) shows cone density map
and examples of cone mosaic imaging at 2 degrees eccentricity in patients with asymptomatic fenestrated slit maculopathy (AFSM) and
macular dystrophy (MD) compared with a healthy subject. Density map showed moderate perifoveal cone loss in AFSM (second and third
rows) and severe generalized cone loss inMD (bottom row). The color code in the bottom row shows cone density (× 103 cells/deg2). Central
2.0 degrees (vertical) - 2.5 degrees (horizontal) is blocked due to lack of resolution to resolve foveal cones. Varying degrees of cone loss was
observed in superior and inferior locations in AFSM and all locations in MD. Panel (B) shows cone density at 2 degrees, 3 degrees, and 4
degrees eccentricities in four meridional directions. The patient with MD had either no or few visible cones in most locations. Both patients
with AFSM had lower cone density at 2 degrees location on all meridians. Additionally, patient II:2 had low cone density at all superior and
inferior locations. The grey zone shows ±2 SD of normal CD values reported by Legras et al.18
MAIA microperimetry in children.35 Taken altogether,
we suggest that microperimetry should be considered
as a feasible method for documenting and monitor-
ing residual retinal function in patients with CRB1-
retinopathy.
Ultra-Widefield FAF Enhances Visualization
of PPRPE in all Patients With CRB1-RP
Although PPRPE in RP was described 4
decades ago for the first time,36 its pathophysiologic
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mechanisms and clinical relevance are yet to be
explored. It has been proposed that release of a
permeable factor from retinal arterioles prevents
degeneration of surrounding structures.36 Whereas
PPRPE was initially linked to CRB1,37 genetic analysis
may fail to detect a mutation in CRB1 in up to one
third of patients with PPRPE.37,38 In addition, there
are reports of CRB1-RP without PPRPE,39 indicating
that PPRPE is neither pathognomonic nor mandatory
for diagnosing CRB1-RP.
The pan-retinal phenotype demonstrated bilateral
PPRPE on ultra-widefield FAF in all our patients
with RP. This feature was less prominent on color
fundus photographs, particularly in those with less
advanced disease. Studies that reported CRB1-RP
without PPRPE either relied on fundus examina-
tion alone15,39 or included patients with LCA.14,40
Moreover, no other gene has been linked to RP with
PPRPE so far, indicating that a thorough genetic analy-
sis may unveil CRB1 mutation. Further studies are
required to investigate the sensitivity and specificity
of PPRPE for CRB1 mutation. However, given the
finding that PPRPE can increase the likelihood of
CRB1 mutations to up to 74%,3,38 we recommend
the use of ultra-widefield FAF imaging in all patients
diagnosed with autosomal recessive RP to look for this
specific sign.
Perifoveal-to-Foveal Volume Ratio: A
Potential Structural End Point in
CRB1-Retinopathy
Perifoveal retinal thickening has been one of
the most consistent findings in CRB1-associated
retinopathies.14,15,41 Jacobson and colleagues reported
significant perifoveal retinal thickening in eight patients
with CRB1-LCA/early-onset RP, whereas the retina
was thinner compared with normal controls in two
patients with RPE65 and one patient with GUCY2D.
They used time-domain OCT (Zeiss Humphrey Instru-
ments, Dublin, CA, USA) to measure cross-sectional
retinal thickness in a single B-scan.14 Using time-
domain Topcon 3D OCT-1000 (Topcon Medical
Systems, Tokyo, Japan), perifoveal retinal thickening
was observed in 77% (10/13)41 and 82% (9/11)15 of
patients with CRB1-RP. In addition, increased central
subfield retinal thickness (CRT) was noted in 36%
(4/11)15 and 62% (8/13) of patients.41 Both CRT
and perifoveal thickness showed an age-dependent
decrease, whichwas attributed to resolution of macular
edema or development of atrophy in the outer
retinal layers with increasing age.41 Unlike all of
the aforementioned studies that report time-domain
OCT thickness results in LCA/RP, we report for
the first time the detailed macular volume profile
using the higher resolution SD-OCT in patients with
both RP and maculopathy. We also introduce novel
OCT parameters, TMV/CSV, and ORV/CSV that are
increased in 89% (8/9) of patients with symptomatic
CRB1-retinopathy. We propose that perifoveal-to-
foveal volume ratio highlights relative foveal thinning
and perifoveal inner retinal thickening, even if both
values are within normal ranges. However, the implica-
tions of this marker in genotype-phenotype correlation
remain to be explored in larger patient cohorts, includ-
ing patients with other genetic diagnoses.
Longitudinal analysis of macular volume parame-
ters revealed a biphasic pattern in CSV and TMV/CSV,
but not in TMV and ORV. None of our patients
had significant macular edema at the time of baseline
imaging for the macular volume study and during
follow-up phase. Hence, in contrast to previous reports
of macular thickness change with increasing age,41
it is unlikely that our observation was confounded
by macular edema. We hypothesize that continued
foveal gliosis after initial resolution of CMO may
be responsible for increasing CSV until the early to
mid-30s. After this phase, progressive foveal thinning
results in decreasing CSV and increasing TMV/CSV
and ORV/CSV with increasing age. Hence, CSV and
TMV/CSV (but not TMV or ORV) might be consid-
ered as surrogate structural end points in CRB1 clini-
cal trials, especially in late-stage disease. However, these
speculations need to be investigated in larger popula-
tions with longer follow-ups and be correlated with
histology.
Asymptomatic Fenestrated Slit Maculopathy:
A Novel CRB1-Maculopathy Phenotype
We detected the common c.498_506del mutation in
3 out of 4 families. This is an in-frame deletion in exon
2, which was classified as a hypomorphic allele and was
reported most frequently in association with CRB1-
associated maculopathy,10 as well as in 6 of 43 CRB1-
associated LCA/RP families, including 1 homozygous
and 5 heterozygous.3 The remaining family (0625) was
diagnosed with compound heterozygous mutations,
including the novel c.652+5G>C mutation, which
is predicted to cause aberrant splicing and is likely
pathogenic, and the previously reported c.2843G>A,
which is a pathogenic missense mutation.13 Regard-
less of causative mutation, the typical natural history
of CRB1-associated MD comprises childhood or
juvenile-onset cystoid maculopathy followed by
progressive macular atrophy and vision loss.7–11
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Cystoid maculopathy can develop at ages as early as 8
years old10 to as late as mid-40s,11 and central atrophy
can occur between the second9 and the fifth11 decades
of life. Clinical presentation of our symptomatic
cases was comparable to those described in previous
reports. In addition, we add long-term natural history
of cystoid maculopathy using serial OCT in two
patients (see Fig. 4), one of them (0237/II:2) reported
as isolated foveal retinoschisis prior to genotyping.42
In addition to patients with typical CRB1-
associated MD, we described 2 asymptomatic cases,
who were siblings of a patient with typical MD, carry-
ing biallelic c.498_506del and c.2843G>A variants
with only subtle outer retinal changes. This novel
AFSMphenotype, which was characterized byAO and
microperimetry, has not been previously reported. In a
series of 7 cases with the c.498_506del allele, 3 patients
(including one homozygous) were asymptomatic at the
time of presentation (10–30 years old), however, their
visual acuity, OCT, and FAF were grossly abnormal.10
Conversely, our patients with AFSM displayed normal
visual acuity and unremarkable OCT findings in the
second decade of life. Long-term follow-up will unveil
whether this new phenotype remains structurally
stable (i.e. forme fruste state) or a preclinical stage
that will evolve into MD as manifested by their sibling
with the same variants. The clinical manifestation
of AFSM may resemble occult macular dystrophy
(OMD), a hereditary macular dystrophy characterized
by foveal dysfunction despite normal fundus appear-
ance. The most common genetic abnormality in OMD
families has been the RP1L1 mutation with autoso-
mal dominant inheritance. Furthermore, patients
with OMD usually present with reduced visual acuity
and central macular dysfunction,43,44 which are not
features found in our AFSM cases.
Limitations
Our study was limited by a lack of ERG data. This
would be useful in those patients with asymptomatic
maculopathy. A baseline multifocal and pattern ERG
could be helpful for detecting subclinical functional
abnormalities in patients with normal visual acuity
and foveal sensitivity. In addition, we have not
provided long-term data for the novel AFSM pheno-
type described.
Conclusions
We showed that PPRPE is best visualized with
ultra-widefield FAF imaging in patients with CRB1-
RP.Microperimetrymay be useful inmonitoring foveal
function in moderate macular dystrophy cases given
our observation of preserved foveal sensitivity. We
found the macular volume profile, especially the ratio
of perifoveal-to-foveal retinal volume, may be used
as a surrogate structural outcome measure in both
pan-retinopathy and maculopathy phenotypes even in
the advanced cases. AFSM may represent a forme
fruste state or preclinical stage of CRB1-associated
MD. Longer term studies are required to validate the
utility of microperimetry and macular volume profile
in measuring disease progression rate. Recognition of
AFSMphenotype provides an opportunity for examin-
ing disease modifying genes or early intervention to
prevent cystoid maculopathy.
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